Cite
HARVARD Citation
Blauvelt, A. et al. (2022). Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study. Journal of dermatological treatment. pp. 2317-2324. [Online].